Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO)
TWD 62.5
(-0.16%)
TWD 62.5
(-0.16%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -48.26 Million | -30.66 Million | -20.12 Million | -9.37 Million | - |
| Net Income | -56.79 Million | -39.8 Million | -27.3 Million | -17.45 Million | - |
| Depreciation & Amortization | 10.5 Million | 9.55 Million | 7.6 Million | 6.04 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 640 Thousand | - | - | - | - |
| Change in working capital | -1.95 Million | 1.9 Million | -512 Thousand | 1.95 Million | - |
| Other non-cash items | -1.75 Million | -1.23 Million | -691 Thousand | -92 Thousand | - |
| Investing Cash Flow | -1.77 Million | 7.66 Million | -4.26 Million | -7.53 Million | - |
| Investments in PPE | -1.51 Million | -7.74 Million | -3.28 Million | -7.91 Million | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | -10 Thousand |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -262 Thousand | -848 Thousand | -981 Thousand | 386 Thousand | - |
| Financing Cash Flow | -2.64 Million | -12.46 Million | 98.61 Million | 78.95 Million | - |
| Debt repayment | - | -10 Million | -10 Million | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | 90 Million | 80 Million | - |
| Other Financing Activities | -2.64 Million | - | - | - | - |
| Accounts receivables | -328 Thousand | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | -179 Thousand | 513 Thousand | -839 Thousand | - | - |
| Other working capital | -1.45 Million | - | - | - | - |
| Cash at beginning of period | 131.11 Million | 166.58 Million | 92.35 Million | 30.31 Million | - |
| Cash at end of period | 78.42 Million | 131.11 Million | 166.58 Million | 92.35 Million | - |
| Capital Expenditure | -1.51 Million | -7.74 Million | -3.28 Million | -7.91 Million | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -52.68 Million | -35.46 Million | 74.22 Million | 62.04 Million | - |
| Free Cash Flow | -49.77 Million | -38.4 Million | -23.41 Million | -17.29 Million | - |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -31.41 Million | -56.79 Million | -31.24 Million | -20.53 Million | -19.13 Million | -39.8 Million |
| Depreciation & Amortization | 5.35 Million | 10.5 Million | 5.19 Million | 5.3 Million | 5.04 Million | 9.55 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 640 Thousand | - | - | - | - |
| Change in working capital | -2.52 Million | -1.95 Million | 1.97 Million | -3.93 Million | 2.81 Million | 1.9 Million |
| Other non-cash items | 16 Thousand | -1.75 Million | 181 Thousand | -5.2 Million | -4.74 Million | -1.23 Million |
| Investing Cash Flow | -4.13 Million | -1.77 Million | -846 Thousand | -933 Thousand | -4.37 Million | 7.66 Million |
| Investments in PPE | -4.87 Million | -1.51 Million | -1 Million | -517 Thousand | -4.37 Million | -7.74 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 10 Thousand | - | - | - | - | - |
| Other Investing Activities | 736 Thousand | -262 Thousand | - | - | - | -848 Thousand |
| Financing Cash Flow | 77.26 Million | -2.64 Million | -1.32 Million | -1.32 Million | -11.33 Million | -12.46 Million |
| Debt repayment | - | - | - | - | -10 Million | -10 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 78.44 Million | - | - | - | - | - |
| Other Financing Activities | -1.17 Million | - | -1.32 Million | -1.32 Million | -1.33 Million | - |
| Accounts receivables | 59 Thousand | - | -398 Thousand | 70 Thousand | 154 Thousand | - |
| Accounts payables | -270 Thousand | - | - | -270 Thousand | 270 Thousand | - |
| Inventory | -166 Thousand | -179 Thousand | 71 Thousand | -250 Thousand | -270 Thousand | 513 Thousand |
| Other working capital | -2.14 Million | - | 2.3 Million | -3.48 Million | 2.65 Million | - |
| Cash at beginning of period | 78.42 Million | 131.11 Million | 104.48 Million | 131.11 Million | 162.84 Million | 166.58 Million |
| Cash at end of period | 123 Million | 78.42 Million | 78.42 Million | 104.48 Million | 131.11 Million | 131.11 Million |
| Capital Expenditure | -4.87 Million | -1.51 Million | -1 Million | -517 Thousand | -4.37 Million | -7.74 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 44.57 Million | -52.68 Million | -26.06 Million | -26.62 Million | -31.73 Million | -35.46 Million |
| Free Cash Flow | -33.44 Million | -49.77 Million | -24.89 Million | -24.88 Million | -20.4 Million | -38.4 Million |
INDSWFTLAB
002358
CIS
BRRLY
GICHSGFIN
BC8